JPRN-UMIN000025065招募中未知
Phase II clinical trial for the effectiveness and safety of AW-PD01 (helium / oxygen mixed gas) for respiratory failure in children and infants with airway stenotic lesions: Single facility single group open label intervention study - Helium-Oxygen gas clinical trial for infant with obstructive airway disease
Tokyo Metropolitan Children's Medical Center0 个研究点目标入组 10 人开始时间: 2016年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 2years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. With cyanotic heart disease 2. With chronic lung disease 3. Receiving a diagnosis of bronchial asthma 4. patients who are judged unsuitable as subjects of the examination by the attending doctor
研究者
相似试验
进行中（未招募）
不适用
Phase II clinical trial to evaluate the efficacy and safety in the use of pancreatic islets cells from cadaver donors for the treatment of Type-I Diabetes Mellitus in renal transplant patients.Type-I Diabetes Mellitus in renal trasplant patientsMedDRA version: 8.1Level: ptClassification code 10061835EUCTR2005-004523-19-ESÁrea de Trasplante y Terapia Celular - Hospital Central de Asturias10
进行中（未招募）
1 期
Phase III clinical trial to evaluate the efficacy and safety of inhaled ethanol in the treatment of early-stage COVID-19.COVID-19EUCTR2020-001760-29-ESSociedad Española de Farmacia Hospitalaria156
进行中（未招募）
1 期
Clinical trial to evaluate the effectiveness and safety of acetazolamide in the treatment of cerebellar syndrome in patients with phosphomannomutase deficiency.Cerebellar syndromeMedDRA version: 19.1Level: PTClassification code 10008072Term: Cerebellar syndromeSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-000810-44-ESFundació Sant Joan de Déu30
已完成
2 期
Phase 2 clinical trial evaluating the efficacy and safety of ART-001 in patients with slow-flow vascular malformationsSlow flow vascular malformationsJPRN-jRCT2071210027agabukuro Hiroshi34
已完成
2 期
Phase 2 clinical trial evaluating the efficacy and safety of ART-648 in patients with bullous pemphigoidMild to moderate bullous pemphigoidJPRN-jRCT2071210034agabukuro Hiroshi30